which is primarily quenched by manganese ions in the reaction buffer. The visualization is then done using ultraviolet light, something that can be produced even by a mobile phone. An additional problem of conventional amplification methods is that the nucleic acid from the clinical material (i.e., swab or aspirate) must be purified before amplification, which is often done by small columns with ion-exchange resins. As this cannot be done in a clinical setting, the authors simply used a urea solution to extract the DNA to overcome the issue.
The device described here is a "proof-of-principle" for a POC test for pertussis. Before entering the field especially in low-and-middle income countries (LMIC), it must undergo additional refinement and further validation in respect to its sensitivity, and especially its specificity and its robustness. Although -after undergoing sufficient validation -the test may be used in less cost-sensitive industrialized countries to facilitate a prompt diagnosis, the most important thing for LMICs will be the final prize of the device, as this would define its usability worldwide.
Being a vaccine-preventable disease, pertussis is notifiable in most countries of the world. The diagnosis of pertussis by (mostly) PCR is a routine procedure in many industrialized countries, whereas most of the cases and most of pertussis mortality, estimated to be around 160,000 infants per year, occur in LMICs in Africa and Asia [8] . WHO and other organizations rightly lament that surveillance of pertussis is insufficient or non-existing especially in those countries, where it is most urgently needed [9] . The lack of surveillance mainly depends on the lack of adequate laboratory facilities in these countries. Thus, after being thoroughly validated for use in LMIC settings, the POC method for detecting Bordetella DNA could offer a first and welcome step for producing data about pertussis incidence in places where the burden of disease is greatest. However, even if POC testing should be possible in the field, some reference laboratory setting is necessary in every country or region to assure that the ongoing circulation of B. pertussis can also be continuously monitored by non-POC conventional methods.
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